chrisvoncsefalvay/vaers-outcomes huggingface dataset:
6/9/09 Mother of the client reported the following events occurred after vaccination of client for Yellow Fever and Typhoid VI at clinic on 5/27/09. 5/28/09 Client had a low grade fever, nausea, loss of appetite, and low energy. 5/29/09 Client c/o same symptoms as previous day and also abd. cramping. Mother took client to Urgent Care Dr. A strep culture was done and client emesed in office. Also emesed later in P.M. at home. The strep test was neg. and when told that the client had received vaccines on 5/27/09 the Dr. felt his symptoms were vaccine related - T 99 degree. 5/30/09 Client no appetite, cramping and diarrhea - 6-7 stools that day. Mother kept client hydrated. 5/30/09 Client c/o nausea and was weak, had a low fever - no diarrhea or vomiting. 6/1/09 Client was taken to school, he c/o cramping and emesed at school. 6/2/09 Client had diarrhea with emesic.  6/3/09 Client woke with c/o cramping. Mother took client to Dr. again.. Dr. indicated that client was likely reacting to Yellow Fever vaccine. Mother was instructed to give client IMODIUM and hydrate. Client had lost 3 lbs. 6/4/09 Client left with relative to another state - had diarrhea stool x 1 and tool IMODIUM. 6/5/09 Client had no vomiting or diarrhea, was in better mood and still had no appetite. 6/6/09 Client flew with relative to another city. Cont. to c/o cramping, low fever. 6/7/09 Client reached destination in a Foreign country. Client c/o being tired with no appetite but had no vomiting or diarrhea. Mother related these events to me 6/8/09 at clinic.
Fever 12 hrs later, swollen lymph node (on side of arm shot) 30 hrs later. gave ibuprofen for fever and pain, warm compress on underarm.
Patient 16 weeks pregnant. Estimated Due Date: 10/31/2022 by LMP
Very tired; chills; muscle aches; This is a spontaneous report from a contactable healthcare professional, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 at 11:45 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes mellitus and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included metformin (MANUFACTURER UNKNOWN), simvastatin (MANUFACTURER UNKNOWN) and echinacea angustifolia, echinacea purpurea (ECHINACEA) from unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021 at 13:00, the patient experienced very tired, chills and muscle aches. Therapeutic measures were not taken as a result of the event. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events very tired, chills and muscle aches were resolved on an unknown date in Apr2021.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 83-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient had no known allergies. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19, included Paxlovid from 29Dec2022 to 03Jan2023.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Dx with Herpes Zoster in one dose varicella vaccine recipient. Treated with IV acyclovir. Unilateral rash, one dermatome. Rash lasted <4 weeks. Also given topical Bactrim. Heart transplant recipient in September 2013.
Fever, muscle aches entire body, chills, shaking, headache, nausea
Information has been received from a pharmacist concerning a patient who on 31-JUL-2007 was vaccinated IM with a 0.5ml dose of Gardasil.  On 02-AUG-2007 the patient was prescribed MEDROL.  The pharmacist reported, "that she did not think that the medication was prescribed to treat an allergic reaction."  The patient's specified details were not known.  Unspecified medical attention was sought.  At the time of the report, the status of the patient was unknown.  Additional information is not expected.
Numbness in both feet with onset 12 days after vaccination.; This is a spontaneous report from a contactable other HCP (herself). A 31-year-old female (Non pregnant) patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EL9265, Expiry date: unknown), via an unspecified route of administration in left arm on 05Feb2021, at 09:30 AM, as single dose for COVID-19 immunisation. The patient medical history included Hashimoto thyroiditis. Patient concomitant medication included Synthroid (LEVOTHYROXINE SODIUM). The patient experienced numbness in both feet with onset 12 days after vaccination on 10Feb2021. Patient visited at physician's office. Patient did not receive any treatment for the event. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had not been tested for COVID-19 since the vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
No adverse event; Patient just received the second vaccine. First dose was administered around MAY2022.; Dose administered after the published expiration date on 27NOV2022.; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient just received the second vaccine. First dose was administered around MAY2022.), EXPIRED PRODUCT ADMINISTERED (Dose administered after the published expiration date on 27NOV2022.) and NO ADVERSE EVENT (No adverse event) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 082B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 06-Dec-2022, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 06-Dec-2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient just received the second vaccine. First dose was administered around MAY2022.) and EXPIRED PRODUCT ADMINISTERED (Dose administered after the published expiration date on 27NOV2022.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient just received the second vaccine. First dose was administered around MAY2022.), EXPIRED PRODUCT ADMINISTERED (Dose administered after the published expiration date on 27NOV2022.) and NO ADVERSE EVENT (No adverse event) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient just received the second vaccine. First dose was administered around MAY2022.) and EXPIRED PRODUCT ADMINISTERED (Dose administered after the published expiration date on 27NOV2022.).    No concomitant medications were reported.  Patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine. First primary series dose given in April 2022. No treatment information was provided.
1 of 2 pts vaxed on 15OCT93 had an adverse event; pt exp itching, redness, swelling & pain w/in 48 hrs p/vax;
Helicobacter pylori; arm pain; a little bit cold; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HELICOBACTER INFECTION (Helicobacter pylori) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure abnormal. Concomitant products included AMLODIPINE for Hypertension.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced PAIN IN EXTREMITY (arm pain) and FEELING COLD (a little bit cold). On an unknown date, the patient experienced HELICOBACTER INFECTION (Helicobacter pylori) (seriousness criterion medically significant). At the time of the report, HELICOBACTER INFECTION (Helicobacter pylori), PAIN IN EXTREMITY (arm pain) and FEELING COLD (a little bit cold) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273, the report did not provide any causality assessment.  The patient was prescribed to take lansoprazole 30 milligrams, amoxicillin 500 milligrams, and clarithromycin 500 milligrams for 14 days to treat Helicobacter pylori.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Dizziness, Myalgia, Fever, NauseaVomiting, Light headed Narrative:
The upper arm  was aching below the injection site and she had a headache on top of her head. Sick in the stomach.
Pt. received PEDIARIX and HEP B (single dose) on 11/18/08
administered to unknown number of patients beyond to Use by date; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered to unknown number of patients beyond to Use by date) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered to unknown number of patients beyond to Use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered to unknown number of patients beyond to Use by date) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that Moderna COVID vaccine Lot#004C21A that had been received at facility and placed in the fridge on 23 Apr and some of the vaccine had been given after the 30 day refrigeration window May 24-June 4.  No concomitant product reported.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: Followup contains no new information.
Received COVID-19 booster vaccine (bivalent PFIZER-BIONTECH) on 9/19/2022 at noon. Patient reports the night of vaccine administration developed blood blisters to bilateral feet Unable to walk much at that time due to bilateral foot pain.  Woke up feeling tired at 1:00 AM, developed muscle aches, soreness, chest tightness, and shortness of breath at 3:30 AM Yesterday morning felt better, but still not back to baseline.  Today, still better, but not back to baseline.
Heart Palpitations  High Resting Heart Rate (about 30 beats above normal) Racing heart when moving from upright to laying down position These symptoms lasted for 3 weeks
Information has been received from the Registered Nurse. It was reported that GARDASIL vaccines were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who had been administered a dose of GARDASIL on 11-DEC-2012 (lot number 670048/0963AA, expiration date 09-NOV-2013) (dose and route not reported). No adverse event was reported. This is one of the reports from the same source. Additional information is not expected.
Felted congested with a headache, sore throat and cough. Took home COVID-19 test and it was positive. Contacted my doctor and was prescribed Paxlovid. Even after taking Paxlovid, cough got really bad, called doctor back and was prescribed Erythromycin. Then started getting better.
tiredness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 02May2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset May2021, outcome "unknown", described as "tiredness".  Additional information: Caller wants to know the side effects of the vaccine, especially tiredness. Caller got the first dose of the vaccine 02May2021. Caller wants to know how long the side effects will last.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient was given a varivax 7/14/23 and an M-M-R on 7/31/23. Patient got the second live vaccine  within 14 days instead of 28 days.  Patient had no adverse reaction, however the third dose must be repeated on 8/28/23.
Quarter size rash under the armpit of the same arm of vaccination; Swollen lymph nodes at collar bone on opposite side of vaccinated arm; This is a spontaneous report from a non-contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 26Mar2021 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date in 2021, about 5 days after the first shot, the patient experienced quarter size rash under the armpit of the same arm of vaccination and lasted approximately 40 days. The patient also experienced swollen lymph nodes at collar bone on opposite side of vaccinated arm. The events resulted in doctor or other healthcare professional office/clinic visit.  Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events quarter size rash under the armpit of the same arm of vaccination and swollen lymph nodes at collar bone on opposite side of vaccinated arm was resolved on an unknown date in 2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Woke up that moning feeling very sick with flu like symptoms and fever of 102.7. Was seen at his Troop Aid Station. Left arm at vaccine red hot and edematous. Was treated with ATB, presented again later that day and was admitted to the hospital with ^ redness and edema to left arm vaccine site. He remained in the hospital for 3 days on IV antibiotics and steroids with serial lab draws.
From the first vaccine, listed, I got a very bad migraine-like headache (only worse), ear and throat ache all on left side. It was so bad I had to go to urgent care. They said it could be vaccine-related bc they'd been seeing this, but I also tested positive for ear infection - given antibiotics. When I got my second dose on 3/13, it gave me very bad arm ache and that went up to the left side of my neck. My neck never stopped hurting. I thought maybe I'd just tensed up so much from my vaccine-related arm pain that the soreness just never left, but as it's been hurting more, doctor finally looked at it, it's a swollen lymph node, having an ultrasound of it, am worried it's vaccine-related
This spontaneous report as received from a physician refers to a 11 year old male patient. About two weeks ago (approximately on 29-JAN-2013) the patient was vaccinated with the first dose of GARDASIL (0.5 ml, intramuscular, lot # was unknown) and had an "injection site reaction, with body aches and swelling at the injection site that necessitated a trip to the emergency room. Concomitant therapies included MENACTRA, TVAP and another unspecified vaccine (manufacturer unknown). The outcome of event was reported as recovered resolved on an unspecified date. The treatment was given for event by unspecified medication for dehydration. The patient had sought unspecified medical attention. Additional information has been requested.
This spontaneous report was received from a pharmacist regarding an unspecified patient of an unknown age and gender. The patient's medical history or concurrent conditions were not provided. In October 2014, the patient was vaccinated with a dose of ZOSTAVAX (dose, route, lot number and expiration date were not provided). On 21-SEP-2015, the patient inadvertently received another dose of ZOSTAVAX (dose, route, lot number and expiration date were not provided). No adverse effects were reported. Additional information has been requested.
4" circular, warm area on RUA; 2" inner area, more firm. (DTAP given in that area).
The patient had swelling, redness, and a warming sensation in her left arm later that night after receiving the vaccinations. The symptoms were localized around the bicep area of her left arm and not around the deltoid where the vaccines were administered. She had a severely reduced range of motion in her left arm the first 24 hours. She described the pain as if her arm had been run over by a car. When she came in on 10/15/17 to the pharmacy the symptoms were slowly going away, but there was some redness and swelling on her left bicep still. Her range of motion had started coming back as well.
Patient developed arm swelling and a bruised area on the skin. Arm has been sore and slightly swollen since reaction started. Patient did report that the arm is getting better but still presented today (10/6/2023) with a what appeared to be a hematoma on her arm near the injection site
pt recv vax 20JUN95 onset of sx 23JUN95 t99 c/o pain & edema lt deltoid w/enlarged axillary nodes lt arm;went to MD 23JUN95 did not see MD;lt deltoid 2"x3" induration noted w/5mm bruise; lymph nodes enlarged lt axillary area; warm to touch
Weakness, Muscle aches all over, vomiting, headache and weakness all lasting 2.5 days.
Erythema spread from site down the leg. Erythema multiforme, on buttocks, face & legs. Topical steroid & BENADRYL.
1pain in right[opposite] shoulder and arm lasted 12 hours   then 2 scalp localized tenderness over 24 hours affected ear pinna then jaw then neck . neck pain persists til today. exam by doctor revealed a red spot oil scalp behind ear,, size of quarter] no evidence trauma or insect bite, no lymphadenopathy.    as of now minor pain , no edema no erythema.  pain was so sever it prevented sleep.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 35 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 29Apr2021 03:30 (Lot number: EW0167) at the age of 35 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "systemic mastocytosis" (unspecified if ongoing); "Meningioma" (unspecified if ongoing); "Allergy" (unspecified if ongoing), notes: known allergies: Yes. Concomitant medication(s) included: CLARITIN [CLARITHROMYCIN]; ALLEGRA; PEPCID [FAMOTIDINE]; SINGULAIR; ASPIRIN [ACETYLSALICYLIC ACID]; ETORICOXIB. The following information was reported: FLUSHING (non-serious) with onset 2021, outcome "recovered", described as "flushed"; PRURITUS (non-serious) with onset 2021, outcome "recovered", described as "felt itchy". Therapeutic measures were taken as a result of flushing, pruritus. Additional information: No other vaccine in four weeks. The patient received Benedryl as treatment for events. The case considered non-serious. Sender's Comments: Linked Report(s) : US-PFIZER INC-202101616420 same patient/drug, different AE and dose.
Patient received Covid-19 Moderna Vaccine @ 0930, 2 minutes after receiving vaccine patient c/o "feeling flushed & dizzy" Provided cot for patient to lay down, VSS 119/73, HR 85, O2 sat 100%, patient denied any SOB/difficulty breathing After 30 minutes of monitoring, patient reported symptoms had resolved
Passed out, hit chin on kitchen cabinet and split open, nausea, dizziness, headache
I started itching around the injection site. Then it spread to my neck area. So, they gave me two Benadryl and watched me for about 30 minutes.
Sore throat- heavy chest - ears ringing and itching- glands itching, tongue tingling. Burning cough.
Had a bad reaction to Moderna vaccine, patient was in bed for 24 hours after getting vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Had a bad reaction to Moderna vaccine, patient was in bed for 24 hours after getting vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (Had a bad reaction to Moderna vaccine, patient was in bed for 24 hours after getting vaccine). At the time of the report, ADVERSE REACTION (Had a bad reaction to Moderna vaccine, patient was in bed for 24 hours after getting vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided No relevant patient history was provided No treatment medications were provided
after first shot:  headache, sun sensitive, runny nose, rash, chills, hard to swallow.   after second shot:  hard to breathe, nausea, fatgiue, bodyaches, dizziness, rash, itching, diarrhea.
not feeling well; Patient has a little bit of a fever; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (not feeling well) and PYREXIA (Patient has a little bit of a fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced PYREXIA (Patient has a little bit of a fever). On an unknown date, the patient experienced FEELING ABNORMAL (not feeling well). At the time of the report, FEELING ABNORMAL (not feeling well) and PYREXIA (Patient has a little bit of a fever) outcome was unknown.            No concomitant medication were provided.  Treatment medication was not provided
pt recv vax 27APR98 secondary later, felt deathly, ill w/lt sided numbness subsequently developing;29APR98 c/o dizziness in waves, otherwise felt fine, dizziness so severe vomited;lt side paresthesia;refused to come to MD ofc poss CVA;